Amen Clinics New York的动态

?? Join Clario for an upcoming webinar to discover how digital endpoint solutions are accelerating breakthroughs in psychiatric drug development! Explore how technologies like electronic clinical outcome assessments (eCOA), medical imaging, and cardiac safety monitoring enhance trial accuracy, improve patient experience, and drive innovation in mental health treatments. Key highlights include: ?? eCOA: Overcoming challenges like placebo response and rater drift with science-led solutions, rater training, and patient education. ?? Medical Imaging: Unlocking insights into brain activity with fMRI to enhance trial design for disorders like MDD, PTSD, and schizophrenia. ?? Cardiac Safety: Managing cardiac risks in psychiatric therapies with 12-lead and continuous ECG monitoring. Attendees will also learn strategies to optimize trial success with real-time data surveillance and patient engagement programs. ??? REGISTER HERE: https://buff.ly/47CAqZg #DrugDevelopment #ClinicalResearch #Biomarkers #PTSD #ClinicalData #eCOA #Schizophrenia #TherapeuticAreas #CNS #Psychiatry #Neuroscience #MajorDepressiveDisorder #Neuropsychiatry

November is National Epilepsy Awareness Month (NEAM), and the call to action is "Share Your Purple Power.” This year’s theme celebrates the unwavering strength, resilience, and courage of epilepsy warriors, alongside their families, caregivers, and advocates. ? This NEAM, we are focusing on four key themes to increase awareness and support the epilepsy community:? ? Belonging - creating a supportive and inclusive community Strength - celebrating the resilience of those impacted by epilepsy Change - driving progress through education and advocacy Impact - making a meaningful difference by raising awareness and breaking down stigma ? To learn more about Epilepsy and find out how you can support the Epilepsy Foundation’s mission, visit www.epilepsy.com. ? #medicaldevice #healthcare #medtech #criticalcare #innovation #neurology #NEAM #epilepsy

Women's Health. Often a great topic of discourse. Can we be doing more? Should we be doing more? What more is there to do? From local anaesthesia for local biopsy during Pap-Smears to a National Screening methods, I often talk to doctors across Psychiatry, Pathology and Radiology about women's health in Ireland. In Psychiatry; Perinatal mental health is so vital, attempting to de-stigmatise and promote consistency of treatment during and post-pregnancy. With Radiologists, I discuss BreastCheck which is an easily accessible service for women aged 50-69 to check for Breast cancer regularly. Leading in awareness and ease of access, the service is used by thousands of women in Ireland annually. (Over 166,000 in 2021 alone). Across Pathology, it is the Cervical Screening and biopsies from BreastCheck follow-up that are the face of women's health. Cervical screening is available free of charge annually for any woman aged 25-65. It's a vast topic, one that will require more than a singular post to cover, but I'd love to know, what are my connections' experience with women's health? I certainly have several horror stories. Care to share your thoughts or experiences below?

?? Enhancing Cognitive Health with HBOT! Did you know Hyperbaric Oxygen Therapy is showing promise in boosting cognitive function among seniors? ?? HBOT involves breathing pure oxygen in a pressurized chamber, which enhances oxygen delivery to the brain, supporting neural repair and cognitive rejuvenation. ???? For older adults, maintaining cognitive abilities is crucial for independence and quality of life. Research indicates HBOT may improve memory, attention, and overall cognitive performance. ?? Exciting developments in healthcare! ?? Interested in learning more about the potential benefits of HBOT for elderly cognition? Let's connect and discuss how innovative therapies are shaping the future of senior care. #HBOT #HyperbaricOxygenTherapy #CognitiveHealth #BrainHealth #ElderCare #AgingWell #HealthyAging #SeniorHealth #Neuroscience #MedicalResearch #HealthcareInnovation #OxygenTherapy #BrainBoost #SeniorLiving #Geriatrics

Congratulations to Elsevier Senior Acquisitions Editor Joslyn Chaiprasert-Paguio and book authors Ayol Samuels (Albert Einstein College of Medicine), David Myland Kaufman (Albert Einstein College of Medicine; MONTEFIORE MEDICAL CENTER), and Audrey Walker (Albert Einstein College of Medicine and MONTEFIORE MEDICAL CENTER) for the publication of "Principles of Pediatric Neuropsychiatry through Complex Clinical Cases". This important reference covers pediatric neuropsychiatry with diverse cases, from Absence Seizures to Klein Levin Syndrome, and provides insights into diagnosis, neuroimaging, and treatment strategies. Key Features: ? Presents the most complex cases in pediatric neuropsychiatry ? Reviews neuroimaging and neuropsychological tests for each case ? Offers strategies for clinicians to effectively communicate diagnosis complexities ? Provides literature reviews from neurological and psychiatric perspectives ? Includes thought-provoking questions at the end of each chapter Whether you're a seasoned practitioner or a budding clinician, this book is a valuable resource for navigating the intricacies of pediatric neuropsychiatry. Get your copy today and embark on a journey towards deeper understanding and enhanced patient care. #PediatricNeuropsychiatry #MedicalEducation #ChildHealth #Neuroscience #Psychiatry

https://lnkd.in/gC2B979X Learn how Ceretype Neuromedicine, Inc.'s advanced #fMRI platform, and scientific expertise from Calyx #MedicalImaging enable you to see the physical action of new treatments on patients with #psychiatric and other #neurological disorders. Read the blog. https://lnkd.in/gHHgKiaz #NeuroPsychiatric #CNS #ClinicalTrials #ChooseCalyx Emily Stern, M.D.

?? Attention healthcare professionals! Join the 2025 EDS ECHO Multidisciplinary Team Practice Program Australasia! The EDS ECHO Multidisciplinary Team Practice (MDTP) Australasia program offers a unique educational experience and networking opportunity for healthcare professionals worldwide. It is designed for those currently involved in clinical work or planning to work with clients with Ehlers-Danlos syndromes (EDS) or hypermobility spectrum disorders (HSD), to improve their ability to care for people with EDS, HSD, and associated symptoms and conditions. Through a comprehensive series of modules, the program will explore patient care in EDS and HSD across the breadth of medicine, surgery, psychiatry, and allied healthcare practice. The program aims to equip participants with the knowledge, skills, and confidence needed to enhance the assessment and management of EDS and HSD, while also promoting collaboration and networking for clinical support. ? Learn more and apply: https://lnkd.in/e2xg6ASJ ? #EDS #HSD #HealthcareEducation #MultidisciplinaryCare #EDSECHO #ProjectECHO #EhlersDanlos #EhlersDanlosSyndrome #Hypermobility #HypermobilitySpectrumDisorder #Medicine #Healthcare #HealthProfessionals ?

I'm excited to share that I am one of the authors of a newly published letter in “Developmental Medicine & Child Neurology” , titled "The Hammersmith Infant Neurological Exam Scoring Aid supports early detection for infants with high probability of cerebral palsy." This letter highlights the critical role of the HINE Scoring Aid in facilitating early detection and intervention for infants at high risk of CP, optimizing developmental outcomes. Our HINE Scoring Aid consolidates crucial information into a single, easy-to-use tool, streamlining the interpretation process for clinicians. This tool supports more efficient and accurate clinical assessments, ensuring timely referrals for early interventions. Collaborating with an incredible team, including Darcy Fehlings, Amber Makino, Paige Church, Karen Thomas, Maureen Luther, Sophie Lam-Damji, Brigitte Vollmer, Leena Haataja, Frances Cowan, Dominico Romeo, Joanne George, and Swetlana Kumar, has been an honor. You can read our publication here: https://lnkd.in/gbrmKSKc #CerebralPalsy #EarlyDetection #Neonatalfollowup #PediatricNeurology #HINE #Research #ChildDevelopment #NICU #BabyCIMT

Alcohol is a toxin to the brain and many other organs. There is no way to sugarcoat it, especially in teens and young adults whose brains are not fully developed. Dr. Daniel Amen is a psychiatrist and brain disorder specialist who has clinics all over the United States and references 5 of the most common ways alcohol affects the human brain. ?? Teens who start to drink heavily between the ages of 12-17 start with less brain volume, and they lose more over time. (Developmental Cognitive Neuroscience, 2014) ?? Lowers blood flow to the brain. With the brain using 20% of the overall blood flow, it's critical for everyday thinking. (Brain fog, impulsivity, poor decision-making) These are the last things our teens need more of... ??1-2 glasses of wine per day, considered "moderate" driving, leads to atrophy of the part of the brain used for memory, mood and critical thinking. No protective effects were found. (BMJ, 2017) ??Decrease the amount of neurogenesis (new brain cell growth). Only animal studies were performed, but these show a 58-63% reduction in the survival of new brain cells. ??A series published in the Journals of Gerontology shows that moderate to heavy drinkers have a 57% risk of dementia. Check out Dr. Amen's Ted Talk. It's a game changer regarding how you will view your brain and brain health. #alcoholabuse #teenmentalhealth #pediatrics #parenting #collegelife

Lasted News| News medical| KMD Bioscience Thursday News Can heparin bring new hope to the fight against dementia? It is estimated that Alzheimer's disease is the fifth leading cause of death among people aged 65 and above in 2021, with over 10 million new cases of dementia diagnosed worldwide each year. In a recent study published in the journal Molecular Psychiatry, researchers explored the potential of heparin therapy in delaying the diagnosis of dementia caused by Alzheimer's disease in individuals aged 65 and above. Their research findings indicate that heparin therapy is associated with a one-year delay in dementia diagnosis in the Mount Sinai Health System (MSHS) and a two-year delay in the Columbia University Medical Center (CUMC), suggesting that this well-known anticoagulant has protective potential and the use of heparin can delay the onset of Alzheimer's disease. https://lnkd.in/dJnPExyr https://lnkd.in/gGxnjc6x #DementiaResearch #AlzheimersAwareness #HeparinHope #MedicalBreakthrough #KMDBioscience #MolecularPsychiatry #Neuroscience #AgingHealth #BrainHealth #DementiaCare #AlzheimersDisease #HealthcareInnovation #AnticoagulantResearch #Newsmedical